Ralph Weichselbaum to Lipoproteins, LDL
This is a "connection" page, showing publications Ralph Weichselbaum has written about Lipoproteins, LDL.
Connection Strength
0.045
-
Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy. Adv Sci (Weinh). 2022 08; 9(24):e2201614.
Score: 0.045